| Home > Authorities > Institutes > Record #113832 |
D120
Angewandte Tumor-Immunität Also known as:D120 Angewandte Tumor-Immunität| ID | I:(DE-He78)D120-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
FcɛR1γ-based activating chimeric antigen receptor enhanced natural killer cell function against HLA-E+ cells.
The journal of immunology 215(2), vkaf284 (2026) [10.1093/jimmun/vkaf284]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Protocol for natural and biomedical image processing in the hypercomplex domain using the 2D orthogonal planes split.
STAR Protocols 7(2), 104548 (2026) [10.1016/j.xpro.2026.104548]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Sacituzumab govitecan in colorectal cancer: clinical evidence and future directions.
Future oncology 22(13), 1581-1591 (2026) [10.1080/14796694.2026.2673807]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Development and Usability of the 'FORTEe Get Strong' App to Promote Physical Activity and Health Awareness in Children and Adolescents With Cancer During Intensive Treatment Using an App-Based Approach: Mixed Methods Study.
JMIR Serious Games 14, e75653 - e75653 (2026) [10.2196/75653]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Detection of MSI signals from peripheral blood for monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: A pilot study.
International journal of cancer 158(12), 3312-3323 (2026) [10.1002/ijc.70387]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial
ESMO gastrointestinal oncology 11, 100297 (2026) [10.1016/j.esmogo.2025.100297]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022.
Breast care 21, 199–211 (2026) [10.1159/000548610]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.
International journal of cancer nn, nn (2026) [10.1002/ijc.70508]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer.
Signal transduction and targeted therapy 11(1), 78 (2026) [10.1038/s41392-026-02594-8]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.
Journal for ImmunoTherapy of Cancer 14(1), e013814 (2026) [10.1136/jitc-2025-013814]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |